| Generalized
Vaccinia (GV) Cases per 1,000,000 Primary Vaccinations(*)
| Age (yrs) |
1968 National Survey(†)
|
1968 10-State
Survey(§¶) |
| 1-4 |
17.6 |
258.7 |
| 5-19 |
11.7 |
157.2 |
| >20 |
45.1 |
242.4 |
| Totals >1 yr |
17.5 |
222.8 |
The 1968 Ten State Survey rates may be over estimates as generalized vaccinia was often confused with other, non-specific immune mediated rashes, such as erythema multiforme, that can occur following vaccination.
| * |
Numbers rounded to the nearest
tenth, total number of vaccinations estimated in both
studies. Observations missing age were distributed according
to the existing age distribution for GV. |
| † |
Case sources include: American
Red Cross Vaccinia Immune Globulin (VIG) distribution
system, Red Cross VIG consultants, State and Territorial
Epidemiologists, Burroughs-Wellcome Thiosemicarbazone
distribution list, smallpox vaccine manufacturers complication
reporting files, state reports to the Encephalitis Surveillance
Unit of the National Communicable Disease Center (NCDC),
and specimen submissions for vaccinia testing to the Viral
Exanthems Unit of NCDC. |
| § |
Case sources include: Physician reporting
via survey in 10 states with active case information follow-up
and chart review for post-vaccinial encephalitis and vaccinia
necrosum reports. |
| ¶ |
Rates may be overestimates
as generalized vaccinia was often confused with other,
non-specific immune-mediated rashes, such as erythema
multiforme, that can occur following vaccination. |
|